Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
08/2005
08/10/2005CN1651036A Angelica root mistletoe granules and its preparation method
08/10/2005CN1651017A Medicinal composition for treating cervical vertebra disease and its preparation method
08/10/2005CN1651014A Chinese medicinal preparation for treating rheumatic and homologus rheumatic artbritis
08/10/2005CN1651011A Chinese medicinal composition for warming and transforming stasis, dispelling dampness and dispersing swell
08/10/2005CN1651010A Chinese medicinal composition for warming and transforming stasis, dispersing swell and engendering bone
08/10/2005CN1650976A Compound saussurea involucrata capsule and its preparation process
08/10/2005CN1650968A Medicinal preparation for treating bone damage disease and its preparation method
08/10/2005CN1650959A Wine for dispelling wind and removing obstruction in channels and its preparation method
08/10/2005CN1650952A Medicine for treating cervical vertebra disease and its preparation method
08/10/2005CN1650941A Plaster for treating knocks and falls, and osteopathia
08/10/2005CN1650938A Chinese medicine external applied powder for bone damage
08/10/2005CN1650932A Tetany resolving tincture
08/10/2005CN1650929A Preparation for free flowing ginew and bone and its preparation method
08/10/2005CN1650923A Medicinal composition for treating theumalism and rheumatism diseases
08/10/2005CN1650898A Manufacturing method of medicine for treating osteosis
08/10/2005CN1214026C Indol-3-yl derivatives
08/10/2005CN1214022C Vitamin D analogues
08/10/2005CN1214011C Meta-azacyclic amino benzoic acid compound and derivatives thereof being integrin antagonists
08/10/2005CN1214008C Therapeutic biaryl derivatives
08/10/2005CN1214006C Novel vitamin D derivatives with cyclopropyl rings in lateral chains, its production method and intermediate and utilization thereof for producing medicaments
08/10/2005CN1213980C Vitamin D analogues
08/10/2005CN1213775C Calcium phosphate artificial bone as osteoconductive and biodegradable bone substitute material
08/10/2005CN1213764C Medicated liquor for treating chronic osteonosus and preparing process thereof
08/10/2005CN1213762C Medicine for invigorating kidney, promoting blood circulation and promoting skeleton formation and its prepn
08/09/2005US6927230 Triazole derivatives
08/09/2005US6927228 Biphenyl compounds usefuf in treatment of human and veterinary medicines such as dermatology, cardivovascular diseases, immune diseases or diseases associated with lipid metabolisms, or in cosmetic formulation
08/09/2005US6927227 Heterocyclic containing biphenyl aP2 inhibitors and method
08/09/2005US6927224 Anticancer agents; osteoporosis
08/09/2005US6927222 Compounds
08/09/2005US6927219 Secondary amides such as N-Adamantan-1-methyl-2-chloro-5-(3,5-dioxo-4,5-dihydro-3H- (1,2,4)triazin-2-yl)-benzamide used as antagonists for biological receptors; antiinflammatiory, anticarcinogenic or antiischemic agents
08/09/2005US6927218 Aryl N-cyanoguanidines and methods related thereto
08/09/2005US6926907 Pharmaceutical compositions for the coordinated delivery of NSAIDs
08/09/2005US6926898 Albumin fusion proteins
08/09/2005CA2310627C Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists
08/09/2005CA2168012C Polymeric matrices and their uses in pharmaceutical compositions
08/09/2005CA2139865C Use of particles of a biocompatible, bioabsorbable calcium salt as active principle in the preparation of a medicament for local treatment of bone demineralizing diseases
08/04/2005WO2004007457A3 Substituted benzylamine derivatives and methods of use
08/04/2005US20050171354 Heterocyclic amines such as (2S,3S)-3-((1R)-6-methoxy-1-methyl -1-trifluoromethylisochroman-7-yl)methylamino-2-phenyl piperidine, used as analgesics, antiinflammatory agents, or for prophylaxis of cardiovascular disorders
08/04/2005US20050171350 Benzhydryl derivatives
08/04/2005US20050171347 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
08/04/2005US20050171346 Proteases, kinases enzyme inhibitors; cardiovascular disorders; central nervous system disorders; antiinflammatrory agents; bone disorders; infections
08/04/2005US20050171345 Pteridine compounds for the treatment of psoriasis
08/04/2005US20050171183 Indole-type inhibitors of p38 kinase
08/04/2005US20050171174 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
08/04/2005US20050171163 MCP-1 receptor antagonists and methods of use thereof
08/04/2005US20050171158 1-(sulfonylaminomethylcarbonyl)-4-cyclohexylpiperidine compounds such as N-[1-(R)-(4-chlorobenzyl)-2-(4-cyclohexyl-4-[1,2,4]triazol-1-ylmethyl-piperidin-1-yl)-2-oxo-ethyl]-methanesulfonamide; various diseases and disorders such as weight control, eating disorders
08/04/2005US20050171128 Pyrrolo[2,3-d]pyrimidine compounds
08/04/2005US20050171125 Novel alkoxypyridine-derivatives
08/04/2005US20050171123 Quinazoline derivatives as medicaments
08/04/2005US20050171122 Mitotic kinesin inhibitors
08/04/2005US20050171117 Preparation of pharmaceutical salts
08/04/2005US20050171111 E.g., 4-[[5-[[4-(3-chlorophenyl)-1,2-dihydro-2-oxo-6-quinolinyl]hydroxymethyl]-1H-imidazol-1-yl]methyl]-benzonitrile; prevents the membrane attachment of p21ras and blocks the aberrant growth of ras-transformed tumors
08/04/2005US20050171101 Neurodegenerative diseases; diseases ascribed by NMDA- and NO-induced neurotoxicity ; ischemia; antiinflammatory; anticancer; antidiabetic; 2-{3-[4-Phenyl-3,6-dihydro-1(2H)-pyridyl]propyl}-6(5H)-phenanthridinone
08/04/2005US20050171096 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
08/04/2005US20050171092 Chemical compounds
08/04/2005US20050171091 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
08/04/2005US20050171075 Substitued 19-nor-cholestenes; antineoplastic agents, wound healing agents, antiinflammatory agents; autoimmune diseases, transplant rejection inhibition, hyperplasia, graft versus host disease; increased cell growth modulation and differentiation, low calcemic activity
08/04/2005US20050171070 Stable salts of o-acetylsalicylic acid containing basic amino acids II
08/04/2005US20050171068 Novel 4-dedimethylaminotetracycline derivatives
08/04/2005US20050171047 Immunostimulatory nucleic acid molecules
08/04/2005US20050171012 Preventives/remedies for bone/joint diseases
08/04/2005US20050171007 Therapeutic method
08/04/2005US20050170327 Isolating thrombocytes from whole blood via agglutinating and sedimenting erthrocytes; regenerative medicine; tisssue engineering
08/04/2005US20050169967 Surgical material comprising water glass fibres
08/04/2005US20050169918 selectively targeting; screening an effect of a Chemokine receptor (CCR4) modulating agent; adjusting the adhesion of T cells to endothelial cells; treating inflammatory skin disease; side effect reduction without affecting on other cells
08/04/2005CA2553232A1 Substituted heterocyclic compounds and methods of use
08/04/2005CA2552763A1 Method of treating type iii hypersensitive reaction-related diseases and conditions by using conjugated linoleic acid
08/03/2005EP1559710A2 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV, process for their preparation and their use
08/03/2005EP1559707A1 Spiro compounds, medicinal compositions containing the same and intermediates of the compounds
08/03/2005EP1559428A1 Receptor regulator
08/03/2005EP1559422A1 Receptor function controlling agent
08/03/2005EP1558650A2 Camelidae antibodies against immunoglobulin e and use thereof for the treatment of allergic disorders
08/03/2005EP1558647A2 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
08/03/2005EP1558646A2 Single domain antibodies directed against interferon- gamma and uses thereof
08/03/2005EP1558645A2 Stabilized single domain antibodies
08/03/2005EP1558618A1 5-(1 ,1 -CYCLOALKYL/ALKENYL)METHYLIDENE 1,2-DIHYDRO- 5H /-CHROMENO[3,4-f ] QUINOLINES AS SELECTIVE PROGESTERONE RECEPTOR MODULATOR COMPOUNDS
08/03/2005EP1558260A2 Quinazolinone compounds as calcilytics
08/03/2005EP1330455B1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same
08/03/2005EP1287017B1 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity
08/03/2005EP1175433B1 Androgen glycosides and androgenic activity thereof
08/03/2005EP1142890B1 Aminopyrazole derivatives
08/03/2005EP1140173B1 Vascular endothelial cell growth factor antagonists and uses thereof
08/03/2005EP1131344B1 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
08/03/2005EP0998288B2 Compositions containing capsaicin or capsaicin analogues and a local anesthetic
08/03/2005CN1649899A Connective tissue stimulating peptides
08/03/2005CN1649895A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
08/03/2005CN1649878A 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof
08/03/2005CN1649876A 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
08/03/2005CN1649869A Azaindoles as inhibitors of c-Jun N-terminal kinases
08/03/2005CN1649867A Novel 1, 2, 3-substituted indolizine derivatives, inhibitors of FGFs, method for making same and pharmaceutical compositions containing same
08/03/2005CN1649863A Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity
08/03/2005CN1649857A Hydroxamic acid derivatives
08/03/2005CN1649855A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
08/03/2005CN1649849A Tachykinin receptor antagonists
08/03/2005CN1649848A Fused pyrimidines derivatives as antagonists of the corticotropin releasing factor (CRF)
08/03/2005CN1649843A Novel chalcone derivatives and uses thereof
08/03/2005CN1649842A 2, 6-quinolinyl and 2, 6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
08/03/2005CN1649841A Piperidine derivative compound and drug containing the same compound as active ingredient
08/03/2005CN1649624A Use of TNF alpha antibodies and another drug
08/03/2005CN1649611A Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
1 ... 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 ... 820